D
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A90.7 KBDeciphera Pharmaceuticals, Inc.Nov 14, 4:01 PM ET·0001172661-24-005149
- 8-K265.8 KBDeciphera Pharmaceuticals, Inc.Jun 11, 9:25 AM ET·0001193125-24-158772
- 10-Q5.8 MBDeciphera Pharmaceuticals, Inc.May 10, 7:27 AM ET·0001654151-24-000018
- 8-K940.5 KBDeciphera Pharmaceuticals, Inc.Apr 29, 7:12 AM ET·0001193125-24-119762
- SC 13G/A102.7 KBDeciphera Pharmaceuticals, Inc.Feb 14, 4:26 PM ET·0001104659-24-023787
- SC 13G/A135.9 KBDeciphera Pharmaceuticals, Inc.Feb 14, 4:06 PM ET·0001140361-24-007972
- SC 13G/A90.8 KBDeciphera Pharmaceuticals, Inc.Feb 14, 2:26 PM ET·0001172661-24-001224
- SC 13G/A13.1 KBDeciphera Pharmaceuticals, Inc.Feb 13, 5:02 PM ET·0001104659-24-020737
- SC 13G/A101.7 KBDeciphera Pharmaceuticals, Inc.Feb 12, 5:32 PM ET·0001193805-24-000192
- SC 13G/A62.5 KBDeciphera Pharmaceuticals, Inc.Feb 9, 4:30 PM ET·0001493152-24-005710
Insiders
10- Allen Patricia LDirector
- Benz Edward J. JRDirector
- Brightstar Associates LLC10% Owner
- Bristol James ArthurDirector
- Dhanak DashyantEVP & Chief Scientific Officer
- Flynn Daniel LeeChief Scientific Officer
- Friedman Franklin StuartDirector
- Hoerter Steven L.Director
- Kelley Susan L.Director
- Kelly Thomas PatrickChief Financial Officer
Tickers
No tickers on record
Addresses
business
200 SMITH STREET
WALTHAM, MA, 02451
mailing
200 SMITH STREET
WALTHAM, MA, 02451
Former Names
- Deciphera Pharmaceuticals, LLC2017-08-15